. In addition, it is most likely that geting cofilin, an actin depolymerizing protein, to late endosomes. As a consequence, the endosomal comthe true value for drug-treated cells with aggregated vacuoles is much higher than 35%, since cells with the partments lost their actin coats and aggregated, but these cells remained morphologically normal, and the strongest drug effect round up, detach, and are preferentially lost during washing steps. Vacuole agglutination kinetics of endocytic marker trafficking were unaltered. Therefore, the actin coat prevents the clustering is readily reversible, and dissociation has a half time of about 20 min after the drug has been removed (Figure of endosomes, which could be one safeguard mechanism precluding their docking and fusion. 1F). Because it takes over 1 hr before the maximum of vacuole aggregation is achieved, it may well be that the actin coat anchors the endosomes and restricts their Results and Discussion mobility; when they lose their coat, they aggregate after oscillatory motion and random collisions. In conclusion, In Dictyostelium amoebae, F-(filamentous) actin is an intact F-actin cytoskeleton is required to keep late, mainly distributed as a thin layer around the circumferneutral endosomes of Dictyostelium in a dispersed state. ence of the cells. Areas within this cortex that are dyAlthough it is conceivable that it is the actin coat surnamic, like the leading edge of a moving cell, or the sites rounding the late vacuoles that prevents their aggregain which phagocytosis or macropinocytosis occurs, are tion, no direct proof can be obtained from drugs affectcharacterized by a dense actin meshwork. In addition, ing the actin cytoskeleton in all locations of the cell. late, neutral endosomes, but not early, acidic ones, are
C terminus (see
). In contrast, an N-terminal fusion of GFP to vacuolin A aggregates in the cell [10]. We refrained from using vacuolin B because the corresponding mutant shows severe defects in the endocytic pathway, whereas vacuolin A function is dispensable to the cell [16] . For identification of the hybrid protein, we included the myc-epitope between the two functional units; the myc-epitope also serves as a flexible linker and may give some freedom to each of the constituents.
A plasmid construct encoding the vacuolin A-myccofilin (VMC) fusion protein (see the Experimental Procedures) was transformed into Dictyostelium cells, and more than ten independent clones were selected. Using the 9E10 antibody to detect the hybrid protein by immunofluorescence, it became apparent that clustered vacuoles are the predominant feature of VMC-expressing clones ( Figure 2A ): they amount to 88.8% Ϯ 0.7% (n ϭ 786 cells), whereas endosome aggregation is observed in only 6.2% Ϯ 1.5% of over 1000 vacuolin A-GFPexpressing cells. These figures are in good agreement with the effects that can be produced by latrunculin treatment of living cells (see above). One major difference between drug-treated cells and VMC-expressing cells is that the former round up and cease motile activities, whereas, in the latter, the effect is limited specifically to the vacuoles and cells show otherwise normal amoeboid morphology. Clusters are dynamic structures. They transiently accommodate individual neutral endosomes, but they do not move over great distances as a whole (see the Supplemental Data).
Counterstaining VMC-expressing cells to visualize F-actin revealed that vacuoles carrying the fusion protein ( Figure 2B ) were devoid of a cytoskeletal coat (Figure 2D) . Accordingly, vacuoles lacking an actin coat aggregate to form huge clusters within the cell, whereas endosomal compartments are typically dispersed in the strain expressing vacuolin A-GFP ( Figure 2C ). Vacuoles bearing a partial actin coat sort out and remain in the periphery of the cluster ( Figure 2F ), and vacuoles that are completely surrounded by a thin layer of actin remain separate even within the same cell (data not shown). It is important to emphasize that the GFP moiety fused to the C terminus of vacuolin A does not interfere with the formation of an actin coat around the endosome ( Figure  2E) . Therefore, the loss of the endosomal actin coat in VMC-expressing cells is not merely a consequence of (Figures 2A and 2B) , and this localization pattern indicates that the targeting affinity of vacuolin predominates. In a clone expressing VMC at higher levels ( Figure 3A) , staining of the cell cortex is observed in addition to the vacuolar labeling ( Figure 3B ) and indicates that excess fusion protein localizes to the F-actin cytoskeleton. To prove that this localization is caused by the cofilin moiety of the fusion protein, we constructed a control strain, expressing myc-tagged cofilin (MC, Figure 3A) . MC accumulates in regions of the dynamic cortex only ( Figure 3C ). Staining endogenous vacuolin in order to monitor the late-endosomal compartment in this strain reveals that vacuoles are dispersed ( Figure 3D ) like in the wild-type cells used as a control above. To address whether excessive VMC expression affects early actin-dependent stages of the endocytic pathway, we measured the efficiency of phagocytosis. Cells expressing VMC at a moderate level internalize particles at a rate similar to the wild-type strain. In strains expressing an increased level of VMC, phagocytosis drops slightly below wild-type rates ( Figure 3E ). We propose that this mild effect is due to the redistribution of excess VMC to the cell cortex, because cells expressing MC only behave the same way ( Figure 3E) 
